adelmidrol has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britti, D; Casili, G; Cordaro, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Gugliandolo, E; Impellizzeri, D; Morittu, VM | 1 |
| Cinelli, MP; D'Amico, A; De Filippis, D; Di Marzo, V; Esposito, G; Iuvone, T | 1 |
2 other study(ies) available for adelmidrol and Chronic Disease
| Article | Year |
|---|---|
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Behavior, Animal; Carrageenan; Chronic Disease; Dicarboxylic Acids; Inflammation; Male; Mast Cells; Mice; Mice, Inbred Strains; NF-KappaB Inhibitor alpha; Pain; Palmitic Acids; Rats; Rats, Sprague-Dawley; Transcription Factor RelA | 2016 |
Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.
Topics: Amides; Animals; Blotting, Western; Carrageenan; Cell Count; Chronic Disease; Dicarboxylic Acids; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Granuloma; Inflammation; Leukocytes; Male; Mast Cells; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Nitrites; Palmitic Acids; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |